Clippard announces issuance of U.S. Patent for the new Eclipse Proportional Isolation Valve

Clippard Instrument Laboratory, Inc., a manufacturer of Precision Flow Control products with focus in the medical, analytical, liquid/gas delivery, laboratory and industrial automation markets, announces that the United States Patent and Trademark Office (USPTO) has issued Patent No. 10,738,904 to Clippard’s new Eclipse Proportional Valve. The Patent, “Flow Control Valve Using Ceramic Valve Members”, will expire in 2040.

Clippard announces issuance of U.S. Patent for the new Eclipse Proportional Isolation Valve
Image Credit: Clippard Instrument Laboratory, Inc.

U.S. Patent No. 10,738,904 covers “a flow control valve that uses two ceramic members having  conforming surfaces which are coupled together to form a fluid-tight seal, and slidable relative to each other to control fluid flow. The shape of the ceramic apertures and their interaction when the valve is opened and closed permits ultra-fine control of the flow of gas or liquid”.

Utilizing the industry’s most robust and powerful miniature linear actuator, the patented  steppercontrolled Eclipse Proportional Isolation Valve leads the industry in performance and durability. This valve is ideal in critical applications for liquid or gas delivery requiring ultra-fine resolution and excellent repeatability. In addition, the unique design allows for custom flow profiles.

  • Leak free (<0.05 sccm)
  • Excellent linearity (<4% of full-scale)
  • Cycle life of typically >1 million
  • Repeatability <0.5% of full travel

For more information on the Eclipse Isolation Valves or any of Clippard’s other 6,000 standard
pneumatic products visit clippard.com or call 877-245-6247.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Clippard Instrument Laboratory, Inc.. (2021, March 09). Clippard announces issuance of U.S. Patent for the new Eclipse Proportional Isolation Valve. News-Medical. Retrieved on November 22, 2024 from https://www.news-medical.net/news/20210309/Clippard-announces-issuance-of-US-Patent-for-the-new-Eclipse-Proportional-Isolation-Valve.aspx.

  • MLA

    Clippard Instrument Laboratory, Inc.. "Clippard announces issuance of U.S. Patent for the new Eclipse Proportional Isolation Valve". News-Medical. 22 November 2024. <https://www.news-medical.net/news/20210309/Clippard-announces-issuance-of-US-Patent-for-the-new-Eclipse-Proportional-Isolation-Valve.aspx>.

  • Chicago

    Clippard Instrument Laboratory, Inc.. "Clippard announces issuance of U.S. Patent for the new Eclipse Proportional Isolation Valve". News-Medical. https://www.news-medical.net/news/20210309/Clippard-announces-issuance-of-US-Patent-for-the-new-Eclipse-Proportional-Isolation-Valve.aspx. (accessed November 22, 2024).

  • Harvard

    Clippard Instrument Laboratory, Inc.. 2021. Clippard announces issuance of U.S. Patent for the new Eclipse Proportional Isolation Valve. News-Medical, viewed 22 November 2024, https://www.news-medical.net/news/20210309/Clippard-announces-issuance-of-US-Patent-for-the-new-Eclipse-Proportional-Isolation-Valve.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.